Related Experiment Video

Updated: May 15, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

C-reactive protein and atherothrombosis: Cause or effect?

Etty Grad1, Haim D Danenberg

  • 1Cardiovascular Research Center, Hadassah Hebrew University Medical Center, Jerusalem, Israel. etty.grad@mail.huji.ac.il

Blood Reviews
|December 26, 2012
PubMed

Insights

C-reactive protein (CRP) minimally impacts atherogenesis but significantly promotes thrombus formation and vascular occlusion, highlighting its role in plaque vulnerability and cardiovascular risk.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Vascular Biology

Background:

  • The inflammatory response is crucial in cardiovascular disease pathogenesis, involving vascular injury and repair.
  • C-reactive protein (CRP) is a key marker of cardiovascular morbidity and influences thromboregulatory pathways.

Purpose of the Study:

  • To investigate the role of CRP in atherogenesis and thrombosis within the atherothrombotic process.
  • To differentiate CRP's contribution to plaque formation versus plaque rupture and subsequent thrombus development.

Main Methods:

  • Review of existing literature on CRP's involvement in cardiovascular disease.
  • Analysis of CRP's presence in atherosclerotic lesions and its correlation with atherogenesis.
  • Evaluation of CRP's impact on thrombotic pathways and vascular occlusion.

Main Results:

  • CRP is present in atherosclerotic lesions but shows minimal correlation with atherogenesis, suggesting it is not pro-atherogenic.
  • CRP actively promotes thrombus formation and vascular occlusion, indicating a role in plaque vulnerability.

Conclusions:

  • CRP primarily contributes to the thrombotic component of atherothrombosis rather than the buildup of atherosclerotic plaque.
  • Understanding CRP's mechanisms can lead to improved diagnostic tools for cardiovascular risk prediction and potential therapeutic strategies.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...